These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3709269)

  • 41. Gentamicin dosage regimen based on serum creatinine concentration.
    Malvino E; Goldenberg D; Giniger R; Casabella A; Jorge M
    Chemotherapy; 1987; 33(5):316-21. PubMed ID: 3665629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)].
    Jacquillat C; Khayat D; Maral J
    Presse Med; 1984 Mar; 13(13):838-40. PubMed ID: 6324161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacokinetics of azlocillin in impaired renal function and haemodialysis (author's transl)].
    Schurig R; Kampf D; Becker H; Förster D
    Arzneimittelforschung; 1979; 29(12a):1944-8. PubMed ID: 543896
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic effect of azlocillin and its combinations with other antibiotics in experimental plague infection].
    Markovskaia EI; Makarovskaia LN; Ryzhkova VV; Zurabian VA
    Antibiot Khimioter; 1993 Jul; 38(7):37-9. PubMed ID: 8161276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of azlocillin-mezlocillin combinations in orthopedic surgery prophylaxis].
    Broggi S
    Boll Chim Farm; 1988; 127(11-12):65S-66S. PubMed ID: 3254251
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibiotic prophylaxis before extracorporeal shock wave lithotripsy by single-shot application of azlocillin.
    Herrlinger A; Bornhof C; Kuehn R
    Chemioterapia; 1987 Jun; 6(2 Suppl):607-9. PubMed ID: 3334645
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment with azlocillin in complicated urinary tract infections.
    Alfthan O; Renkonen OV; Ohlsson H
    Arzneimittelforschung; 1979; 29(12a):1979-81. PubMed ID: 543906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.
    Colaizzi PA; Polk RE; Poynor WJ; Raffalovich AC; Cefali EA; Beightol LA
    Antimicrob Agents Chemother; 1986 May; 29(5):938-40. PubMed ID: 3729353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dosage adjustment for ceftazidime in patients with impaired renal function.
    van Dalen R; Vree TB; Baars AM; Termond E
    Eur J Clin Pharmacol; 1986; 30(5):597-605. PubMed ID: 3530782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Degradation of azlocillin in human serum.
    Schönfeld W; Knöller J; Bremm KD; König W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):254-9. PubMed ID: 3002076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A high serum concentration of azlocillin affects routine biochemical analyses.
    Gunneberg A; Gillett MG; Goldie DJ
    Ann Clin Biochem; 1993 May; 30 ( Pt 3)():329-30. PubMed ID: 8517619
    [No Abstract]   [Full Text] [Related]  

  • 53. The tolerance and safety of azlocillin.
    Parry MF
    J Antimicrob Chemother; 1983 May; 11 Suppl B():223-8. PubMed ID: 6619031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-dose kinetics and dosage of mecillinam in renal failure and haemodialysis.
    Schapira A
    Clin Pharmacokinet; 1984; 9(4):364-70. PubMed ID: 6088153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effect of continuous arteriovenous hemofiltration on the pharmacokinetics of azlocillin in anuric patients].
    Krupp A; Leuwer M; Schmidt H; Eberhardt B
    Anaesthesist; 1990 May; 39(5):275-8. PubMed ID: 2192573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmakokinetic and clinical studies with azlocillin in paediatrics (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH
    Klin Padiatr; 1980 Sep; 192(5):419-29. PubMed ID: 7192337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of azlocillin in bronchial secretions.
    Gouin F; Condomines M; Mallet MN; Albanese J; Sauh P; Martin C; De Micco P
    Chemioterapia; 1987 Jun; 6(2 Suppl):256-7. PubMed ID: 3509402
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
    Vilde JL; Vachon F; Humbert G; Bure A; Bricaire F
    Presse Med; 1984 Mar; 13(13):822-4. PubMed ID: 6231604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of azlocillin in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Kinderarztl Prax; 1986 Sep; 54(9):527-33. PubMed ID: 3795720
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical results with azlocillin (author's transl)].
    Schacht P; Tettenborn D; Hullmann R; Bruck H
    Arzneimittelforschung; 1979; 29(12a):1981-5. PubMed ID: 396929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.